Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 29, 2026 8-K
SCHEDULE 13G Aug 12, 2026
10-Q Aug 6, 2026 10-Q
8-K Jul 30, 2026 8-K
SCHEDULE 13G/A Jul 27, 2026
8-K Jul 15, 2026 8-K
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
3 Jun 11, 2026 3
8-K Jun 10, 2026 8-K
4 Jun 5, 2026 4
SCHEDULE 13G/A May 15, 2026
10-Q May 7, 2026 10-Q
8-K May 1, 2026 8-K
ARS Apr 27, 2026 ARS
DEFA14A Apr 27, 2026 DEFA14A
DEF 14A Apr 27, 2026 DEF 14A
8-K Apr 20, 2026 8-K
8-K Apr 1, 2026 8-K
4 Mar 31, 2026 4
← Newer Page 1 of 26 · 646 filings Older →